Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Codivir in Hospitalized Patients with Moderate COVID-19
NCT05218356Phase 2Recruiting
- Sponsor
- Code Pharma
- Start
- Jan 2022
- Primary completion
- Dec 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Codivir in coronavirus disease 2019 (COVID-19), sponsored by Code Pharma. Started Jan 2022; status: recruiting.
02
Drugs
Codivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05218356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05218356.